Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12671512 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL29764073 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL1875231 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| SCHEMBL23802704 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL16479551 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| SCHEMBL23802703 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL10024738 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL20540234 | 1.00 | SLC6A9 (0.43) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL21618318 | 0.98 | SLC6A9 (0.42) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 | |
| Calcobutrol SCHEMBL14834269 | 0.98 | SLC6A9 (0.42) | SLC6A9HSD17B10CACNA2D1CACNA1BCACNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192864-B2 | Method for producing calcobutrol | ENZYCHEM LIFESCIENCES CORPORATION (KR) | 2021-12-07 | — | — | US | disclosed |
| US-20200385358-A1 | METHOD FOR PRODUCING CALCOBUTROL | ENZYCHEM LIFESCIENCES CORPORATION (KR) | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200385358-A1 | METHOD FOR PRODUCING CALCOBUTROL | CALCB, CACYBP, CALCA | SLC6A9 1746/4885HSD17B10 2997/4885CACNA2D1 330/4885 |
| US-11192864-B2 | Method for producing calcobutrol | CALCB, CACYBP, CALCA | SLC6A9 1746/4885HSD17B10 2997/4885CACNA2D1 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.